Featured Research

from universities, journals, and other organizations

Discontinuation of smokeless tobacco (snus) after myocardial infarction linked to improved survival

Date:
August 29, 2011
Source:
European Society of Cardiology (ESC)
Summary:
In a prospective cohort study, discontinuation of smokeless tobacco after a myocardial infarction (MI) is associated with a lower risk of subsequent mortality. Investigators found that post MI snus quitters had a 44 % lower risk of total mortality.The association seems to be independent of smoking habits, but partly explained by concomitant changes in other lifestyle variables.

In a prospective cohort study, presented at the ESC Congress 2011, discontinuation of smokeless tobacco after a myocardial infarction (MI) is associated with a lower risk of subsequent mortality. Investigators found that post MI snus quitters had a 44 % lower risk of total mortality.

The association seems to be independent of smoking habits, but partly explained by concomitant changes in other lifestyle variables.

Smokeless tobacco in the form of Swedish snus (oral moist snuff) has been advocated as a safer alternative to smoking. Snus takes the form of a finely ground and moistened tobacco, a bolus of which is placed under the upper lip for around an hour, with daily exposure times estimated to be around 10 to 12 hours. Different formulations exist from loose tobacco to sachets. In Sweden, 20% of adult males and 4% of adult females are estimated to be daily users. The sale of snus is illegal in the rest of the European Union, but widespread and increasing in the United States.

"While cigarettes are indeed associated with more negative health effects, smokeless tobacco can't be regarded as harmless," said Gabriel Arefalk from Uppsala University (Uppsala, Sweden), the first author of the study. "In Sweden every time we discharge an MI patient who's a snus user, we're faced with the clinically important question of whether they should discontinue use."

Of concern, he added, has been a meta-analysis suggesting that use of smokeless tobacco results in an increased risk for fatal MIs, indicating that snus use may predispose people to arrhythmic or other serious complications of MIs.

In the current prospective cohort study, 20,911 consecutive patients aged 75 years or less who had been admitted between 2005 and 2009 to coronary care units for an MI in Sweden, were followed. Two months post discharge, information about risk factors such as past and present tobacco exposure, diabetes, hypertension, body mass index and waist circumference was recorded, as well as more specific potential confounding factors such as type of MI (STEMI/NSTEMI), participation in cardiac rehabilitation programs, level of physical activity and occupation status.

During a mean follow-up of 2.1 years, 812 of the participants died. Among the 1799 current snus users, 69 died (incidence rate 18.7 per 1000 person-years-at-risk); versus 14 among the 675 post MI snus quitters (incidence rate 9.7 per 1000 person-years-at-risk).

In a model adjusted for age, gender and present and past smoking status, the investigators found that post MI snus quitters had a 44 % lower risk of total mortality (hazard ratio 0.56; 95% confidence interval [CI] 0.31-0.99) relative to current snus users. While in a model that was further adjusted for diabetes, hypertension, systolic and diastolic blood pressures, body mass index, waist circumference, type of MI, participation in cardiac rehabilitation programs, level of physical activity and occupational status, snus quitters had a non-significant 32 % lower risk than current users (hazard ratio 0.68; 95% CI 0.38-1.21).

"The reduced risk in snus quitters seemed to be independent of smoking habits but may be partly related to changes in other life style behaviors, such as level of physical activity and participation in cardiac rehabilitation programs," said Arefalk. "Ideally the effects of quitting snus post-MI should be studied in a randomised clinical trial," he added.


Story Source:

The above story is based on materials provided by European Society of Cardiology (ESC). Note: Materials may be edited for content and length.


Cite This Page:

European Society of Cardiology (ESC). "Discontinuation of smokeless tobacco (snus) after myocardial infarction linked to improved survival." ScienceDaily. ScienceDaily, 29 August 2011. <www.sciencedaily.com/releases/2011/08/110829070505.htm>.
European Society of Cardiology (ESC). (2011, August 29). Discontinuation of smokeless tobacco (snus) after myocardial infarction linked to improved survival. ScienceDaily. Retrieved September 18, 2014 from www.sciencedaily.com/releases/2011/08/110829070505.htm
European Society of Cardiology (ESC). "Discontinuation of smokeless tobacco (snus) after myocardial infarction linked to improved survival." ScienceDaily. www.sciencedaily.com/releases/2011/08/110829070505.htm (accessed September 18, 2014).

Share This



More Health & Medicine News

Thursday, September 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com
What HealthKit Bug Means For Your iOS Fitness Apps

What HealthKit Bug Means For Your iOS Fitness Apps

Newsy (Sep. 18, 2014) Apple has delayed the launch of the HealthKit app platform, citing a bug. Video provided by Newsy
Powered by NewsLook.com
Residents Vaccinated as Haiti Fights Cholera Epidemic

Residents Vaccinated as Haiti Fights Cholera Epidemic

AFP (Sep. 18, 2014) Haitians receive the second dose of the vaccine against cholera as part of the UN's vaccination campaign. Duration: 00:34 Video provided by AFP
Powered by NewsLook.com
Raw: Elephant Undergoes Surgery in Tbilisi Zoo

Raw: Elephant Undergoes Surgery in Tbilisi Zoo

AP (Sep. 18, 2014) Grand the elephant has successfully undergone surgery to remove a portion of infected tusk at Tbilisi Zoo in Georgia. British veterinary surgeons used an electric drill to extract the infected piece. (Sept. 18) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins